Speciality glass manufacturer Schott is to build a second melting tank for pharmaceutical glass tubing at its main plant in Mainz, Germany costing €40 million.

The new production facility is scheduled to go into operation in mid-2022 and will then offer 100 new jobs, 50 of which will be directly at Schott.

With this investment, Schott has said it is responding to the increasing global demand for glass tubing for pharmaceutical packaging.

"We decided in favour of the Mainz site in order to further strengthen our production base for pharmaceutical glass tubing in Germany and Europe”, explained Dr. Frank Heinricht, Chairman of the Board of Management of Schott.

He added: “In doing so, we naturally also have our sights set on the manufacturers of COVID-19 pandemic vaccines based here and the European pharmaceutical industry as a whole.”

Due to the importance of this capacity expansion for the health care system in Germany and Europe, Schott is also in talks with the regional government of Rhineland-Palatinate, the federal government of Germany and the European Union.

The pharmaceutical glass production in Mainz is part of a global production network of the Tubing Business Unit, which also includes the Mitterteich site in Germany as well as factories in Brazil, India and China.

Schott has already expanded its production capacities for pharmaceutical tubing in Asia in the autumn of 2020 with the commissioning of another tank in India and a completely new plant in China.